neuro42 Receives FDA Clearance on Portable and Compact Brain MRI Scanner for Point of Care Imaging

livemint.com:

News XT Network, March 8: neuro42, Inc. (“neuro42" or the “Company"), a medical technology Company leading the innovation of MRI and robotics for brain related diagnosis and treatment, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration for its portable diagnostic MRI scanner.

neuro42’s MRI System eliminates the need to transport a patient to an imaging suite, enabling timely diagnosis and improving treatment outcomes for patients with critical neurological conditions. Accomplished entrepreneur and lead investor, Krishna Bhupal, who was appointed to the neuro42 Board of Directors in October last year, is helping launch the product in the Indian market. He says “neuro42 MRI is already receiving exciting reviews in India.

We have gathered serious enquiries from government and private medical facilities in several states including Telangana, Maharashtra, and Karnataka. With the FDA clearance, we will be able to serve these markets later this year." Krishna said, “I am delighted to be a part of neuro42’s journey to develop and market pioneering MR and robot technologies for neurosurgical intervention, which will change the economics of accessibility, availability and accessibility of healthcare. I look forward to the Company’s next phase of growth and for it to significant player in India’s transforming healthcare ecosystem".

Disclaimer: This article is a paid publication and does not have journalistic/editorial involvement of Hindustan Times. Hindustan Times does not endorse/subscribe to the content(s) of the article/advertisement and/or view(s) expressed herein. Hindustan Times shall not in any manner, be responsible and/or liable in any manner whatsoever for all that is stated in